Table 3 Reasons for discontinuation of first choice anticoagulant and frequency of alternative choice anticoagulants (N = 80)
Frequency (%) | |
|---|---|
Reason for discontinuation | |
Patient-reported permanent return to sinus rhythm | 16 (20.0) |
Contraindication | 12 (15.0) |
Physician’s recommendation | 10 (12.5) |
Difficulty reaching INR 2–3 (VKA only) | 9 (11.3) |
Major or clinically-relevant non-major bleed | 9 (11.3) |
Thromboembolism | 6 (7.5) |
Minor bleeding | 5 (6.3) |
Renal insufficiency | 3 (1.1) |
Patient´s wish | 3 (1.1) |
other | 7 (8.8) |
Alternative choice anticoagulant | |
Vitamin-K-Antagonist | 16 (20.0) |
Dabigatran | 8 (10.0) |
Rivaroxaban | 16 (20.0) |
Apixaban | 18 (22.5) |
LMWH (long-term) | 5 (6.3) |
None | 17 (21.3) |